Drug intelligence / Profile preview

dextromethorphan + guaifenesin (Yabang Epson Pharmaceutical)

Development stage: Unknown
Lead developer: Jiangsu Yabang Epson Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Yuemei Capsule (I) is an approved oral fixed-dose cough medicine containing **guaifenesin 100 mg** and **dextromethorphan hydrobromide 10 mg** per capsule. Guaifenesin is an expectorant that helps loosen respiratory secretions, while dextromethorphan is a centrally acting antitussive that suppresses coughing. The product is indicated for cough and sputum associated with upper respiratory tract infection and bronchitis. The supplied company-pipeline context identifies Jiangsu Yabang Epson Pharmaceutical as a marketer/manufacturer of Yuemei capsules. The Chinese regulator's 2026 notice identifies Yuemei Capsule (I) as a prescription-managed product with this exact active-ingredient composition. ([nmpa.gov.cn](https://www.nmpa.gov.cn/directory/web/nmpa/images/1788227955298095785.docx))

Brand names: Keyuning
Other names: Guaifenesin and Dextromethorphan Hydrobromide Capsules (I)YuemeiYuemei Capsule (I)愈美胶囊（Ⅰ）

Beyond the preview

Go deeper on dextromethorphan + guaifenesin (Yabang Epson Pharmaceutical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on dextromethorphan + guaifenesin (Yabang Epson Pharmaceutical).

Explore the full profile